The nation of Zimbabwe has declined a significant American health deal worth 367 million US dollars (272 million pounds) over five years because of Washington's insistence on sensitive information.
This move was revealed following a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "skewed".
A government spokesperson has since explained that the US was requesting genetic material for research and profit while was unwilling to share the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for more negotiations to reach a agreement suitable to all parties so the nation's critical HIV treatment initiative can continue.
Broader Context
This rejection follows a comparable case in neighbouring Kenya, where a court suspended a related health funding agreement after legal challenges were raised about the security of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government agreements to boost openness and accountability.
Based on statements, 16 nations in Africa have to date agreed to these new agreements, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to surrender its biological resources and data for a long time, without any equivalent guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"Effectively, our country would supply the basic resources for medical research with no certainty that the resulting innovations would be accessible to our citizens should a future health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending systems already established via the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This framework is intended to ensure that when a nation contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome continued dialogue with our US partners on how future co-operation might be arranged in a way that respects the sovereignty and dignity of each country."
Medical Community Response
Medical experts said it acknowledged the government's concerns, but suggested that talks need to persist given that much of the country's HIV programmes were funded by external financing.
"In cases where technical issues exist, including those involving information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it said.
The halted deal emphasises the continuing challenges between accepting vital international aid and protecting national sovereignty in an increasingly data-driven world.